Correlation of the factors on benign prostatic hyperplasia combined with obstruction
Chen, Q.; Wang, Y.-X.
Zhonghua Nan Ke Xue 8(4): 299-301
2002
ISSN/ISBN: 1009-3591 PMID: 12491701 Document Number: 547100
Benign prostate obstruction(BPO) means bladder outlet obstruction (BOO) due to benign prostatic hyperplasia (BPH), which concerns BPH, and lower urinary tract symptoms(LUTS). To treat the BPO is the main purpose of therapy on BPH in clinic. This review includes recent advances in study of changes on urodynamics(UDS), morphology, prostatic composition, which occur in BPO.
Document emailed within 1 workday
Related Documents
Liang, Y.-y.; Cao, M.-x.; Dai, Y.-p.; Liang, W.-j.; Zheng, K.-l. 2006: Diagnostic value of urodynamic parameters multianalysis in the evaluation of bladder outlet obstruction resulting from benign prostatic hyperplasia Zhonghua Nan Ke Xue 12(9): 818-821Jonas, U.; Melchior, H.; Rübben, H. 1998: Recommendations for billing alternative therapy of benign prostatic hyperplasia. Laser therapy of benign prostatic hyperplasia Der Urologe. Ausg. a 37(1): 110-111
Gao, W.-J.; Wang, Y.-M.; Wang, C.-H.; Yang, X.-K.; Wan, L.; Li, W.-P. 2013: Expressions of SIgA and alpha 1-AR in benign prostatic hyperplasia combined with chronic prostatitis and their implications Zhonghua Nan Ke Xue 19(4): 315-320
Boyle, P. 1994: Epidemiology of benign prostatic hyperplasia: risk factors and concomitance with hypertension British Journal of Clinical Practice. Suppl 74: 18-22
Karpukhin, I.V.; Li, A.A.; Bogomol'nyĭ, V.A. 1999: Physical factors in the rehabilitative treatment of patients with benign prostatic hyperplasia Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 6: 48-52
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103
Gu, R.-Z.; Xia, S.-J. 2011: Surgical options for benign prostatic hyperplasia: impact on sexual function and risk factors Zhonghua Nan Ke Xue 17(9): 837-841
Miyake, K.; Yamamoto, M.; Kanai, S.; Mitsuya, H. 1986: Combined prostatectomy and retropubic prostatectomy on patients eighty years old or older with benign prostatic hyperplasia Hinyokika Kiyo. Acta Urologica Japonica 32(7): 977-980
Brannen, G.E.; Coffey, D.S. 1977: Tumor-specific immunity in patients with prostatic adenocarcinoma or benign prostatic hyperplasia Cancer Treatment Reports 61(2): 211-216
Kletscher, B.A.; Oesterling, J.E. 1995: Prostatic stents. Current perspectives for the management of benign prostatic hyperplasia Urologic Clinics of North America 22(2): 423-430
Gu, F. 2000: Epidemiological survey of benign prostatic hyperplasia and prostatic cancer in China Chinese Medical Journal 113(4): 299-302
Pretlow, T.G.; Whitehurst, G.B.; Pretlow, T.P.; Hunt, R.S.; Jacobs, J.M.; McKenzie, D.R.; McDaniel, H.G.; Hall, L.M.; Bradley, E.L. 1982: Decrease in creatine kinase in human prostatic carcinoma compared to benign prostatic hyperplasia Cancer Research 42(11): 4842-4848
Granados Loarca, E.A. 1999: Medical treatment of benign prostatic hyperplasia. The efficacy of finasteride depends on prostatic volume Archivos Espanoles de Urologia 52(3): 201-208
Abdul-Muhsin, H.M.; Jakob, N.J.; McLemore, R.M.; McAdams, S.B.; Humphreys, M.R. 2016: Infectious complications associated with the use of temporary prostatic urethral stents in patients with benign prostatic hyperplasia Canadian Journal of Urology 23(5): 8465-8470
Blanc, M.; Sacrini, A.; Avogadro, A.; Gattamorta, M.; Lazzerini, F.; Gattoni, F.; Cretti, F. 1998: Prostatic volume: suprapubic versus transrectal ultrasonography in the control of benign prostatic hyperplasia La Radiologia Medica 95(3): 182-187
Maygarden, S.J.; Strom, S.; Ware, J.L. 1992: Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia Archives of Pathology and Laboratory Medicine 116(3): 269-273
Schönberger, B. 1986: Benign prostatic hyperplasia Zentralblatt für Chirurgie 111(10): 569-588
Hiraoka, Y.; Sa, I. 2002: Biochemical diagnosis of benign prostatic hyperplasia (including differential diagnosis with prostatic carcinoma) Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 11): 342-345
Neal, D.E.; Hegarty, P. 2003: Key questions in benign prostatic hyperplasia Practitioner 247(1652): 886-889
Tan, E.C. 1995: Pharmacotherapy in benign prostatic hyperplasia Annals of the Academy of Medicine Singapore 24(4): 615-618